Greenyn Biotechnology Co., Ltd (6846.TWO)

TWD 77.8

(0.0%)

Market Cap (In TWD)

2.09 Billion

Revenue (In TWD)

800.51 Million

Net Income (In TWD)

130.66 Million

Avg. Volume

13.12 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
71.0-84.0
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006846009
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
-
Employee Count
-
Website
https://www.greenynbio.com
Ipo Date
2022-04-19
Details
Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulation series, man power series, women's intimate health series, and mature woman series. In addition, the company offers customization, ODM, dosage, and application services. Greenyn Biotechnology Co., Ltd was founded in 2012 and is based in Taichung, Taiwan.